DETERMINATION OF FACTORS ASSOCIATED WITH LONG-TERM ENDOTHELIAL LOSS AND REFRACTIVE RESULT IN PATIENTS WITH ARTISAN PHAKIC LENS

Stáhnout PDF English version

Autoři: LC. Martinez ^1,3; A. Tello ^2,3,4,6; V. Galvis ^2,3,4,6; SJ. Villamizar ^4,5,6; DV. Nova ³
Působiště autorů: Department of Ophthalmology, Universidad Industrial de, Santander Bucaramanga, Santander, Colombia ¹; Department of Anterior Segment, Fundación Oftalmológica, Santander FOSCAL, Floridablanca, Santander, Colombia ²; Department of Ophthalmology, Fundación Oftalmológica, Santander FOSCAL, Floridablanca, Santander, Colombia ³; Centro Oftamológico Virgilio Galvis, Floridablanca, Santander, Colombia ⁴; Department of Epidemiology. Centro Oftamológico Virgilio Galvis, Floridablanca, Santander, Colombia ⁵; Department of Ophthalmology, Universidad Autónoma de, Bucaramanga, Bucaramanga, Colombia ⁶
Vyšlo v časopise: Čes. a slov. Oftal., 78, 2022, No. 4, p. 188-195
Kategorie: Původní práce
doi: https://doi.org/10.31348/2022/21

Souhrn

Purpose: To determine the changes in endothelial cell density, refractive results, and risk factors associated with endothelial loss in patients with irisclaw phakic intraocular lenses for myopia/myopic astigmatism (Artisan).

Methodology: Data collection was obtained from an existing database with information on patients with a phakic Artisan lens implant between 1998 and 2011 at the Virgilio Galvis Ophthalmology Centre, with at least 5 years of follow-up. As a second stage, an analysis was carried out to identify the change in endothelial cell density and its potential associated factors.

Results: A total of 80 eyes with myopic errors were included with a follow-up of 11.9 + 3.48 years. The percentage of total loss of endothelial cells was greater than 25% of the preoperative density in 43.8% of the eyes. A postoperative annual loss > 1.6% was found in 47.0% of the eyes with that information available. 41 eyes (51%) had final endothelial density < 2000 cells/mm2, and 7 (8.8%) eyes had endothelial cell density < 1000 cells/mm2. Among the variables studied, no associated factors for long-term endothelial loss were found. During the course of the study, 8 (10%) phakic intraocular lenses were explanted, including 3 with accelerated endothelial loss, and another 2 with cataract associated and a significantly low endothelial density. The last mean spherical equivalent was -0.81 (±1.01 D), and the final uncorrected distance visual acuity was 0.45 logMar (Snellen 20/56).

Conclusion: Artisan-type phakic lenses are a good alternative for the correction of high myopic defects, with predictable refractive results in the long term. However, there is an increased loss of endothelial cells in the long term in a high percentage of patients. Strict postoperative follow-up, including endothelial evaluation, is required, and further studies are warranted.

Klíčová slova:

Refractive surgery – intraocular phakic lens – loss of endothelial cells – corneal oedema – corneal endothelium

Zdroje

1. Bourne WM, Nelson LIL, Hodge DO. Central corneal endothelial cell changes over a ten-year period. Investig Ophthalmol Vis Sci. 1997;38(3):779-782.

2. Fechner PU, Haigis W, Wichmann W. Posterior chamber myopia lenses in phakic eyes. J Cataract Refract Surg [Internet]. 1996 Mar [cited 2018 Apr 15];22(2):178-182. Available from: http://www. ncbi.nlm.nih.gov/pubmed/8656381

3. Lifshitz T, Levy J, Aizenman I, Klemperer I, Levinger S. Artisan phakic intraocular lens for correcting high myopia. Int Ophthalmol. 2005;25(4):233-238.

4. Landesz M, Worst JG, Siertsema J V, van Rij G. Correction of high myopia with the Worst myopia claw intraocular lens. J Refract Surg [Internet]. [cited 2018 Apr 15];11(1):16-25. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/7641044

5. Benedetti S, Casamenti V, Benedetti M. Long-term endothelial changes in phakic eyes after Artisan intraocular lens implantation to correct myopia. Five-year study. J Cataract Refract Surg. 2007;33(5):784-790.

6. Stulting RD, John ME, Maloney RK, Assil KK, Arrowsmith PN, Thompson VM. Three-Year Results of Artisan/Verisyse Phakic Intraocular Lens Implantation. Ophthalmology [Internet]. 2008 Mar [cited 2018 Apr 15];115(3):464-472.e1. Available from: http://linkinghub. elsevier.com/retrieve/pii/S0161642007009578

7. Hassaballa MA, Macky TA. Phakic intraocular lenses outcomes and complications: Artisan vs Visian ICL. Eye. 2011;25(10):1365-1370.

8. Galvis V, Villamil JF, Acuña MF, et al. Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®). Graefe’s Arch Clin Exp Ophthalmol. 2019;257(12):2775-2787.

9. Güell JL, Morral M, Gris O, Gaytan J, Sisquella M, Manero F. Five- Year Follow-up of 399 Phakic Artisan-Verisyse Implantation for Myopia, Hyperopia, and/or Astigmatism. Ophthalmology. 2008;115(6):1002-1012.

10. Van Eijden R, de Vries NE, Cruysberg LPJ, Webers CA, Berenschot T, Nuijts RMMA. Case of late-onset corneal decompensation after iris-fixated phakic intraocular lens implantation. J Cataract Refract Surg [Internet]. 2009;35(4):774-777. Available from: http://dx.doi. org/10.1016/j.jcrs.2008.09.032

11. Shajari M, Scheffel M, Koss MJ, Kohnen T. Dependency of endothelial cell loss on anterior chamber depth within first 4 years after implantation of iris-supported phakic intraocular lenses to treat high myopia. J Cataract Refract Surg [Internet]. 2016;42(11):1562-1569.Available from: http://dx.doi. org/10.1016/j.jcrs.2016.08.027

12. Saxena R, Boekhoorn SS, Mulder PGH, Noordzij B, van Rij G, Luyten GPM. Long-term Follow-up of Endothelial Cell Change after Artisan Phakic Intraocular Lens Implantation. Ophthalmology. 2008;115(4):7-9.

13. Jonker SMR, Berendschot TTJM, Ronden AE, Saelens IEY, Bauer NJC, Nuijts RMMA. Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses. 5- and 10-Year Results. Ophthalmology [Internet]. 2017;(June 2016):1-9. Available from: http://dx.doi.org/10.1016/j.ophtha. 2017.08.011

14. Bernard P FM. Definitive stop of marketing, product recall and follow- up of implanted patients. Presbyopia intraocular lenses NEWLIFE/ VIVARTE PRESBYOPIC. Agence Française Sécurité Sanit des Prod Santé. 2006;8.

15. MacRae S, Holladay JT, Hilmantel G, et al. Special Report: American Academy of Ophthalmology Task Force Recommendations for Specular Microscopy for Phakic Intraocular Lenses. Ophthalmology [Internet]. 2017;124(1):141-142. Available from: http://dx.doi. org/10.1016/j.ophtha.2016.09.034

16. Bouheraoua N, Bonnet C, Labbé A, et al. Iris-fixated phakic intraocular lens implantation to correct myopia and a predictive model of endothelial cell loss. J Cataract Refract Surg. 2015 Nov;41(11):2450- 2457. doi: 10.1016/j.jcrs.2015.05.030. PMID: 26703496.

17. Doors M, Cals DWJK, Berendschot TTJM, et al. Influence of anterior chamber morphometrics on endothelial cell changes after phakic intraocular lens implantation. J Cataract Refract Surg. 2008;34(12):2110-2118.

18. Nemcova I, Pasta J, Hladikova K, et al. Myopic Correction with Iris-Fixated Phakic Intraocular Lenses: Twelve-Year Results. J Ophthalmol. 2021;2021 Available from: https://doi. org/10.1155/2021/7027793